BeStock  
Stocks › Biotechnology › TRVI

Trevi Therapeutics TRVI

US equityMarket cap rank #2705Biotechnology
$13.35 −$0.37 (-2.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $13.35 0.00%
Open$13.58
Prev close$13.72
Day range$13.23 – $13.90
Volume2.09M
Market cap$1.90B
P/E (TTM)–
Dividend yield–

TRVI Stock News

Headlines matching Trevi Therapeutics or the TRVI ticker, most recent first.

  • Trevi Therapeutics (TRVI) Receives a Buy From H.C. WainwrightTipRanks · 22 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $24Market news · 22 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Trevi Therapeutics(TRVI.US), With a Forecast Between $23 to $40Market news · 8 Aug 2026 · Direct mention
  • Trevi Therapeutics (TRVI) Receives a New Rating From B. Riley SecuritiesTipRanks · 7 Aug 2026 · Direct mention
  • Oppenheimer Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $25 PositiveMarket news · 7 Aug 2026 · Direct mention
  • Stifel Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $30Market news · 7 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $23 PositiveMarket news · 7 Aug 2026 · Direct mention
  • JonesTrading Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $28 PositiveMarket news · 14 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $23Market news · 10 Aug 2026 · Direct mention
  • BMO Capital Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $36Market news · 21 Jul 2026 · Direct mention
  • BMO Capital Initiates Trevi Therapeutics(TRVI.US) With Buy Rating, Announces Target Price $36Market news · 21 Jul 2026 · Direct mention
  • H.C. Wainwright Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $24 PositiveMarket news · 20 Jul 2026 · Direct mention
  • Needham Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $23Market news · 17 Jul 2026 · Direct mention
  • Clear Street Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Raises Target Price to $29 PositiveMarket news · 8 May 2026 · Direct mention
  • H.C. Wainwright Maintains Trevi Therapeutics(TRVI.US) With Buy Rating, Maintains Target Price $21Market news · 8 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on TRVI.

Sign in to join the discussion.

Scroll to Top